Nerve Growth Factor Shows Biphasic Expression during Adjuvant-Induced Neurogenic Inflammation

Int J Mol Sci. 2024 Apr 4;25(7):4029. doi: 10.3390/ijms25074029.

Abstract

Chronic inflammatory diseases are considered the most significant cause of death worldwide. Current treatments for inflammatory diseases are limited due to the lack of understanding of the biological factors involved in early-stage disease progression. Nerve growth factor (NGF) is a neurotrophic factor directly associated with inflammatory and autoimmune diseases like osteoarthritis, multiple sclerosis, and rheumatoid arthritis. It has been shown that NGF levels are significantly upregulated at the site of inflammation and play a crucial role in developing a robust inflammatory response. However, little is known about NGF's temporal expression profile during the initial progressive phase of inflammation. This study aimed to determine the temporal expression patterns of NGF in rat skin (epidermis) during adjuvant-induced arthritis (AIA). Sprague Dawley rats were randomly divided into control and complete Freund's adjuvant (CFA)-treated groups. Levels of NGF were evaluated following unilateral AIA at different time points, and it was found that peripheral inflammation due to AIA significantly upregulated the expression of NGF mRNA and protein in a biphasic pattern. These results suggest that NGF signaling is crucial for initiating and maintaining peripheral neurogenic inflammation in rats during AIA.

Keywords: NGF-TrkA signaling; acute inflammation; biphasic; inflammation; nerve growth factor (NGF); neurogenic inflammation; nociception.

MeSH terms

  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic
  • Animals
  • Inflammation
  • Nerve Growth Factor* / genetics
  • Neurogenic Inflammation*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Nerve Growth Factor
  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic